ARS Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 10.86 M | $87.00 M | 0.00% | 10.94% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2026 | 8.54 M | $68.41 M | 6.76% | 8.60% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 8.29 M | $66.39 M | 0.00% | 8.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 7.50 M | $60.11 M | 0.00% | 7.56% |
| BLACKROCK, INC. | 08/07/2026 | 5.31 M | $42.54 M | 5.97% | 5.35% |
| TYRO CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.46 M | $35.72 M | 50.22% | 4.49% |
| ABRDN PLC | 07/31/2026 | 4.17 M | $33.41 M | 1.39% | 4.20% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/12/2026 | 4.01 M | $32.14 M | 0.00% | 4.04% |
| STATE STREET CORP | 08/07/2026 | 3.73 M | $29.88 M | 2.35% | 3.76% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 2.75 M | $22.07 M | 100.00% | 2.77% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.55 M | $20.45 M | 0.43% | 2.57% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.40 M | $19.23 M | -59.87% | 2.42% |
| JANNEY MONTGOMERY SCOTT LLC | 08/05/2026 | 2.06 M | $16.54 M | 2.38% | 2.08% |
| UBS GROUP AG | 08/13/2026 | 1.94 M | $15.54 M | -14.19% | 1.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.70 M | $13.61 M | 11.28% | 1.71% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 1.60 M | $12.83 M | 539.08% | 1.61% |
| GENERAL AMERICAN INVESTORS CO INC | 07/31/2026 | 1.13 M | $9.08 M | 55.82% | 1.14% |
| THIRD POINT LLC | 08/14/2026 | 1.00 M | $8.01 M | 0.00% | 1.01% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 07/17/2026 | 672.14 K | $5.38 M | 100.00% | 0.68% |
| TEJARA CAPITAL LTD | 08/11/2026 | 607.04 K | $4.86 M | 188.52% | 0.61% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 601.00 K | $4.81 M | -55.86% | 0.61% |
| PAVAKI CAPITAL MANAGEMENT LLC | 08/07/2026 | 579.60 K | $4.64 M | 0.59% | 0.58% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 566.83 K | $4.54 M | 11.02% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 551.42 K | $4.42 M | 3.38% | 0.56% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 551.42 K | $4.42 M | 100.00% | 0.56% |
| NORTHERN TRUST CORP | 08/13/2026 | 549.06 K | $4.40 M | 3.74% | 0.55% |
| LEVIN CAPITAL STRATEGIES, L.P. | 07/31/2026 | 548.97 K | $4.40 M | -0.65% | 0.55% |
| CITADEL ADVISORS LLC | 09/02/2026 | 531.06 K | $4.25 M | -70.05% | 0.53% |
| EMPIRE LIFE INVESTMENTS INC. | 07/24/2026 | 471.86 K | $3.78 M | -5.47% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 463.26 K | $3.71 M | 62.13% | 0.47% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 461.38 K | $3.70 M | -0.71% | 0.46% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 461.00 K | $3.69 M | 3.29% | 0.46% |
| FIL LTD | 08/13/2026 | 455.58 K | $3.65 M | 0.00% | 0.46% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 380.77 K | $3.05 M | -47.42% | 0.38% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 377.01 K | $3.02 M | 176.73% | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 08/07/2026 | 375.13 K | $3.00 M | -32.98% | 0.38% |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 08/03/2026 | 373.49 K | $2.99 M | 4.02% | 0.38% |
| JPMORGAN CHASE & CO | 08/12/2026 | 363.32 K | $3.11 M | -5.09% | 0.37% |
| FMR LLC | 08/13/2026 | 349.16 K | $2.80 M | 2.08% | 0.35% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 318.58 K | $2.55 M | -39.34% | 0.32% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 286.73 K | $2.30 M | 100.00% | 0.29% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 255.20 K | $2.04 M | 100.00% | 0.26% |
| MORGAN STANLEY | 08/13/2026 | 229.10 K | $1.84 M | -27.65% | 0.23% |
| FAS WEALTH PARTNERS, INC. | 07/29/2026 | 214.51 K | $1.72 M | 4.43% | 0.22% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 175.61 K | $1.41 M | 100.00% | 0.18% |
| QUINN OPPORTUNITY PARTNERS LLC | 08/14/2026 | 175.00 K | $1.40 M | 12.90% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 168.14 K | $1.35 M | 2.48% | 0.17% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 164.29 K | $1.32 M | 17.95% | 0.17% |
| NUVEEN, LLC | 08/11/2026 | 161.34 K | $1.29 M | 7.06% | 0.16% |
| ISHARA INVESTMENTS LP | 08/14/2026 | 143.49 K | $1.15 M | 100.00% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 261 institutional investors and hedge funds held shares of ARS Pharmaceuticals Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
Rubric Capital Management LP: 8.54 M
ORBIMED ADVISORS LLC: 8.29 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 7.5 M
BlackRock, Inc.: 5.31 M
Tyro Capital Management LLC: 4.46 M
91.80% of ARS Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 100.64 M shares in the last 24 months. This purchase volume represents approximately $910.81 M in transactions.